Jay Spiegel, MD

Articles by Jay Spiegel, MD

Drs. Dahiya, Spiegel Explore Link Between CAR-T, Secondary Malignancies

Chadi Nabhan, MD, MBA, FACPTransplantation & Cellular Therapy | January 26, 2024

The latest HemOnc Pulse episode looks at the science behind the statement from the FDA on the risk of CAR-T therapies.

Jay Spiegel, MD, Discusses Results from the US Lymphoma CAR-T Cell Consortium

Jay Spiegel, MDAggressive B-Cell Lymphoma | December 14, 2023

Dr. Spiegel shared five-year data from a retrospective study of 298 patients with LBCL who received axi-cel.